April 2026
The global alpha emitter market size is evaluated at USD 696.72 billion in 2025 and is predicted to reach around USD 1,753.40 billion by 2035, with a CAGR of 9.67%.
November 2025
The global alpha-1 antitrypsin deficiency augmentation therapy market size is estimated to hit around USD 2.96 billion by 2034 from USD 1.73 billion in 2025, at a CAGR of 6.14%.